Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: abdominal pain major surgical or invasive procedure: 1. ercp with sphincterotomy, stent placement 2. laproscopic cholecystectomy history of present illness: 80yo female s/p ercp @ which was unsuccessful for presumed choledocholithiasis found on mrcp last tuesday after ruq u/s was done prior to that for ruq pain was equivocal. pt has had intermittent fevers, but was not given abx. also had rigors at that time but all resolved. denies postprandial pain. notes had "attacks" x 3 beginning early . tolerating pos, but c/o +n/v yesterday and today. past medical history: medhx: htn, gerd, hyperlipidemia, goiter, hiatal hernia, diverticulitis surghx: total thyroidectomy, tah, appendectomy social history: denies tobacco/drug use. infrequent etoh. family history: noncontributory physical exam: vs 101.6 86 149/69 18 96% on 2l nc nad, aaox3, uncomfortable perrla, eomi rrr abd soft, distended/tympanic, ttp ruq. + sign. no rebound/guarding ext w/o c/c/e pertinent results: 06:10pm urine blood-sm nitrite-neg protein-tr glucose-neg ketone-neg bilirubin-sm urobilngn-4* ph-5.0 leuk-neg . 06:10pm blood wbc-19.7* rbc-4.16* hgb-11.8* hct-36.4 mcv-88 mch-28.3 mchc-32.3 rdw-13.1 plt ct-331 01:26am blood wbc-15.4* rbc-3.32* hgb-9.4* hct-27.6* mcv-83 mch-28.4 mchc-34.2 rdw-13.5 plt ct-261 12:47am blood wbc-17.6* rbc-3.32* hgb-9.3* hct-28.8* mcv-87 mch-27.9 mchc-32.2 rdw-13.2 plt ct-272 . 06:10pm blood glucose-124* urean-20 creat-1.2* na-141 k-4.1 cl-106 hco3-25 angap-14 12:47am blood glucose-133* urean-16 creat-1.3* na-140 k-4.1 cl-109* hco3-22 angap-13 . 06:10pm blood alt-157* ast-181* ld(ldh)-258* alkphos-358* amylase-* totbili-2.8* dirbili-2.3* indbili-0.5 01:26am blood alt-113* ast-102* alkphos-266* amylase-1110* totbili-1.2 dirbili-0.7* indbili-0.5 12:47am blood alt-75* ast-40 alkphos-228* amylase-264* totbili-0.5 . mrcp: indication: failed mrcp. evaluate gallbladder and common bile duct. comparison: comparison was made with the previous ct from . technique: multiplanar t1- and t2-weighted images were acquired on a 1.5 tesla magnet, including dynamic high-resolution 3d imaging, obtained prior to, during, and after the uneventful intravenous administration of 0.1 mmol/kg of gadolinium-dtpa. 2d and 3d reformations and subtraction images were generated on an independent workstation. mri abdomen findings: there is a large hiatal hernia. the liver is visualized and is of normal signal intensity. note is made of multiple lesions of high signal intensity scattered throughout the liver on the t2- weighted imaging that do not enhance post-administration of contrast and are consistent with cysts. no focal enhancing lesions within the liver. the spleen is visualized and is normal. the adrenals are normal. some cysts are seen in relation to the right kidney that are simple in nature. a septated cyst in seen in the lower pole of the left kidney that is septated. this cyst measures 3.1 cm x 3.3 cm (series 8, image 30). it does not demonstrate enhancement post administration of contrast. the pancreas is poorly visualized as a non-breathhold imaging technique was employed. the common bile duct is enlarged at 12 mm. note is made of multiple calculi within the common bile duct. two small calculi are seen in the mid common bile duct (series 8, image 20) and three further calculi are seen in the distal cbd (series 8, image 21). the distalmost calculus is seen at the distal cbd, and may be causing the obstruction. no evidence of any pancreatic ductal dilatation. the bowel where visualized is normal. degenerative changes noted in the lumbar spine with dextroconvex scoliosis. no evidence of any free fluid. 2d and 3d reformations provided multiple perspectives for the dynamic series. note is made of bilateral pleural effusions and associated atelectasis. impression: 1. choledocholithiasis and apparent distal cbd obstruction with resultant intrahepatic and extra- hepatic bile duct dilatation. 2. renal cysts with septated left interpolar cyst, but no nodularity or enhancement noted. 3. degenerative change in the spine and some scattered hemangiomata. 4. incompletely evaluated pancreas due to non-breathhold technique. brief hospital course: this is a 80yo female who was transferred from with choledocholithiasis and probable cholangitis s/p failed ercp with resultant mild pancreatitis. pt was initially admitted to the sicu and was transferred to the floor on hd#3 as her clinical status improved. . *) cholangitis: pt was started on zosyn iv. she was seen by gi, who recommended holding off on ercp in light of her clinical improvement during the short time since her transfer. she had an mrcp on hd#3 which showed 4 stones in the common bile duct. she underwent ercp with successful removal of the stones, as well as sphincterotomy and stent placement on hd#5. as her labs and exam continued to improve, she also underwent overall uncomplicated laproscopic cholecystectomy on hd#6. please see full operative note for details. . *) postoperative course: postoperatively, she required re-intubation secondary to decreased respiratory drive. she remained intubated for approximately 6 hours postop, during which time she received lasix for pulmonary edema. her ekg was unchanged and 3 sets of cardiac enzymes for negative. she was able to be successfully extubated and postoperative course was otherwise uncomplicated. her diet was slowly advanced postoperatively and she tolerated a regular diet prior to discharge. pain was well controlled with an oral regimen. . *) mild pancreatitis: pt was kept npo until hd#3, when she began to tolerate liquids and her symptoms improved. . pt was discharged home on hd#9/pod#3 in stable condition to follow up with dr. . medications on admission: synthroid, atenolol, nexium, celebrex, glucosamine discharge medications: 1. atenolol 50 mg tablet sig: one (1) tablet po daily (daily). 2. levothyroxine 100 mcg tablet sig: one (1) tablet po daily (daily). 3. oxycodone 5 mg tablet sig: one (1) tablet po q6h (every 6 hours) as needed for pain. disp:*40 tablet(s)* refills:*0* 4. docusate sodium 100 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* 5. amoxicillin-pot clavulanate 875-125 mg tablet sig: one (1) tablet po bid (2 times a day) for 10 days. disp:*20 tablet(s)* refills:*0* 6. miralax 17 gram (100 %) powder in packet sig: one (1) packet po once a day. disp:*30 packets* refills:*2* discharge disposition: home discharge diagnosis: cholangitis, mild post-ercp pancreatitis discharge condition: stable discharge instructions: please call your doctor or return to the er for any of the following: * you experience new chest pain, pressure, squeezing or tightness. * new or worsening cough or wheezing. * if you are vomiting and cannot keep in fluids or your medications. * you are getting dehydrated due to continued vomiting, diarrhea or other reasons. * signs of dehydration include dry mouth, rapid heartbeat or feeling dizzy or faint when standing. * you see blood or dark/black material when you vomit or have a bowel movement. * your skin, or the whites of your eyes become yellow. * your pain is not improving within 8-12 hours or not gone within 24 hours. call or return immediately if your pain is getting worse or is changing location or moving to your chest or back. * you have shaking chills, or a fever greater than 101.5 (f) degrees or 38(c) degrees. * any serious change in your symptoms, or any new symptoms that concern you. . * please resume all regular home medications and take any new meds as ordered. * do not drive or operate heavy machinery while taking any narcotic pain medication. you may have constipation when taking narcotic pain medications (oxycodone, percocet, vicodin, hydrocodone, dilaudid, etc.); you should continue drinking fluids, you may take stool softeners, and should eat foods that are high in fiber. * continue to increase activity daily * no heavy lifting (> lbs) for 6 weeks. followup instructions: please call dr. () to schedule an appointment to have your stent removed, unless you are able to have it removed at . you can call dr. office to schedule a follow up appointment. procedure: continuous invasive mechanical ventilation for less than 96 consecutive hours insertion of endotracheal tube endoscopic removal of stone(s) from biliary tract endoscopic sphincterotomy and papillotomy laparoscopic cholecystectomy endoscopic insertion of stent (tube) into bile duct diagnoses: anemia, unspecified esophageal reflux unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene other and unspecified hyperlipidemia cholangitis acute pancreatitis calculus of gallbladder and bile duct with other cholecystitis, with obstruction cyst of kidney, acquired postsurgical hypothyroidism 

Answer: The patient is high likely exposed to